Literature DB >> 16375901

Delta and mu opioid receptors from the brain of a urodele amphibian, the rough-skinned newt Taricha granulosa: cloning, heterologous expression, and pharmacological characterization.

C Samuel Bradford1, Eliza A Walthers, David J Stanley, Martha M Baugh, Frank L Moore.   

Abstract

Two full-length cDNAs, encoding delta (delta) and mu (mu) opioid receptors, were cloned from the brain of the rough-skinned newt Taricha granulosa, complementing previous work from our laboratory describing the cloning of newt brain kappa (kappa) and ORL1 opioid receptors. The newt delta receptor shares 82% amino acid sequence identity with a frog delta receptor and lower (68-70%) identity with orthologous receptors cloned from mammals and zebrafish. The newt mu receptor shares 79% sequence identity with a frog mu receptor, 72% identity with mammalian mu receptors, and 66-69% identity with mu receptors cloned from teleost fishes. Membranes isolated from COS-7 cells transiently expressing the newt delta receptor possessed a single, high-affinity (Kd = 2.4 nM) binding site for the nonselective opioid antagonist [3H]naloxone. In competition binding assays, the newt delta receptor displayed highest affinity for Met-enkephalin, relatively low affinity for Leu-enkephalin, beta-endorphin, and [D-penicillamine, D-penicillamine] enkephalin (DPDPE) (a delta-selective agonist in mammals), and very low affinity for mu-, kappa-, or ORL1-selective agonists. COS-7 cells expressing the newt mu receptor also possessed a high-affinity (Kd = 0.44 nM) naloxone-binding site that showed highest affinity for beta-endorphin, moderate-to-low affinity for Met-enkephalin and Leu-enkephalin and DAMGO (a mu-selective agonist in mammals), and very low affinity for DPDPE and kappa- or ORL1-selective agonists. COS-7 cells expressing either receptor type (delta or mu) showed very high affinity (Kd = 0.1-0.3 nM) for the nonselective opioid antagonist diprenorphine. Taricha granulosa expresses the same four subtypes (delta, mu, kappa, and ORL1) of opioid receptors found in other vertebrate classes, but ligand selectivity appears less stringent in the newt than has been documented in mammals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16375901     DOI: 10.1016/j.ygcen.2005.11.002

Source DB:  PubMed          Journal:  Gen Comp Endocrinol        ISSN: 0016-6480            Impact factor:   2.822


  7 in total

Review 1.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

2.  Evolution of vertebrate opioid receptors.

Authors:  Susanne Dreborg; Görel Sundström; Tomas A Larsson; Dan Larhammar
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-01       Impact factor: 11.205

3.  Single Amino Acid Variation Underlies Species-Specific Sensitivity to Amphibian Skin-Derived Opioid-like Peptides.

Authors:  Eyal Vardy; Maria F Sassano; Andrew J Rennekamp; Wesley K Kroeze; Philip D Mosier; Richard B Westkaemper; Craig W Stevens; Vsevolod Katritch; Raymond C Stevens; Randall T Peterson; Bryan L Roth
Journal:  Chem Biol       Date:  2015-06-18

4.  Cloning and bioinformatics of amphibian mu, delta, kappa, and nociceptin opioid receptors expressed in brain tissue: evidence for opioid receptor divergence in mammals.

Authors:  Craig W Stevens; Christopher M Brasel; Shekher Mohan
Journal:  Neurosci Lett       Date:  2007-04-11       Impact factor: 3.046

5.  In vivo regulation of the μ opioid receptor: role of the endogenous opioid agents.

Authors:  Veronica Gonzalez-Nunez; Ada Jimenez González; Katherine Barreto-Valer; Raquel E Rodríguez
Journal:  Mol Med       Date:  2013-03-05       Impact factor: 6.354

6.  A pharmacological comparison of the cloned frog and human mu opioid receptors reveals differences in opioid affinity and function.

Authors:  Chris M Brasel; Gregory W Sawyer; Craig W Stevens
Journal:  Eur J Pharmacol       Date:  2008-10-09       Impact factor: 4.432

Review 7.  The evolution of vertebrate opioid receptors.

Authors:  Craig W Stevens
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.